DOR BioPharma, Inc. (DOR) is a late-stage biopharmaceutical company committed to the development of life-saving therapeutics and vaccines. DOR has two areas of focus: 1) a therapeutics platform dedicated to the development of products for life-threatening conditions such as gastrointestinal Graft-versus-Host disease and cancer, and 2) a biodefense platform to develop vaccines for military and civilian applications.

Website: www.dorbiopharma.com
 
 
 
 
 
 
Moody Capital Solutions, Inc. | 208 Summitrail Lane | Dawsonville | Georgia | 30534 | P 706.216.0180 | F 706.993.3276



developed by kaizen web solutions